Showing results (11-20 of 6,664) with videos related to
Sort By:
Pageof 667
Annals of Hematology|September 17, 2020
Very-low-dose decitabine treatment for patients with intermediate- or high-risk myelodysplastic syndrome: a retrospective analysis of thirteen casesKaiji Zhang, Ying Lian, Xiaohong Guan, et al.Annals of Hematology|May 29, 2021
Severe homocysteinemia in two givosiran-treated porphyria patients: is free heme deficiency the culprit?Petro E Petrides, Michael Klein, Elfriede Schuhmann, et al.Annals of Hematology|October 2, 2020
Is there a gender effect in polycythemia vera?Francesca Palandri, Barbara Mora, Naseema Gangat, et al.Annals of Hematology|January 29, 2020
Impact of clinical features, cytogenetics, genetic mutations, and methylation dynamics of CDKN2B and DLC-1 promoters on treatment response to azacitidineIván Martín, Blanca Navarro, Alicia Serrano, et al.Annals of Hematology|December 23, 2022
Efficacy and safety of ruxolitinib in patients with newly-diagnosed polycythemia vera: futility analysis of the RuxoBEAT clinical trial of the GSG-MPN study groupSteffen Koschmieder, Susanne Isfort, Dominik Wolf, et al.Annals of Hematology|June 20, 2021
Pre-transplant donor-type red cell transfusion is a safe and effective strategy to reduce isohemagglutinin titers and prevent donor marrow infusion reactions in major ABO-mismatched transplantsPallavi Mehta, Stalin Ramprakash, C P Raghuram, et al.Annals of Hematology|January 12, 2023
Improved benefit of continuing luspatercept therapy: sub-analysis of patients with lower-risk MDS in the MEDALIST studyUlrich Germing, Pierre Fenaux, Uwe Platzbecker, et al.Annals of Hematology|January 9, 2023
Whole-exome sequencing identifies FANC heterozygous germline mutation as an adverse factor for immunosuppressive therapy in Chinese aplastic anemia patients aged 40 or younger: a single-center retrospective studyYingying Shen, Qi Liu, Hangchao Li, et al.Annals of Hematology|January 12, 2023
Re-induction therapy in patients with acute myeloid leukemia not in complete remission after the first course of treatmentWeijia Fu, Yue Hu, Guihua Lu, et al.Annals of Hematology|May 31, 2022
Comprehensive comparison of international prognostic indexes for follicular helper T-cell lymphomaYong-Pyo Lee, Sang Eun Yoon, Junhun Cho, et al.Pageof 667